Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 103
of 6Next
1:

The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.

Provan SA, Angel K, Odegård S, Mowinckel P, Atar D, Kvien TK.

Arthritis Res Ther. 2008;10(3):R70. Epub 2008 Jun 23.

PMID: 18573197 [PubMed - in process]

2:

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID: 15811980 [PubMed - indexed for MEDLINE]

3:

Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.

Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM.

Arthritis Rheum. 2008 Sep;58(9):2662-9.

PMID: 18759301 [PubMed - in process]

4:

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA.

JAMA. 2007 Jan 10;297(2):169-76.

PMID: 17213400 [PubMed - indexed for MEDLINE]

5:

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.

Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.

PMID: 16937127 [PubMed - indexed for MEDLINE]

6:

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.

Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L.

J Am Coll Cardiol. 2005 Feb 15;45(4):533-41.

PMID: 15708700 [PubMed - indexed for MEDLINE]

7:

N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.

Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.

Circulation. 2004 Nov 16;110(20):3206-12. Epub 2004 Nov 8.

PMID: 15533869 [PubMed - indexed for MEDLINE]

8:

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.

Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.

Am J Med. 2006 Apr;119(4):355.e1-8.

PMID: 16564781 [PubMed - indexed for MEDLINE]

9:

Cardiac biomarkers and survival in haemodialysis patients.

Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M.

Eur J Clin Invest. 2007 May;37(5):350-6.

PMID: 17461980 [PubMed - indexed for MEDLINE]

10:

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.

James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L.

Circulation. 2003 Jul 22;108(3):275-81. Epub 2003 Jul 7.

PMID: 12847065 [PubMed - indexed for MEDLINE]

11:

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.

J Hypertens. 2006 Aug;24(8):1531-9.

PMID: 16877955 [PubMed - indexed for MEDLINE]

12:

Limited Utilities of N-terminal pro B-type natriuretic peptide (NT-proBNP) and Other Newer Risk Markers Compared with Traditional Risk Factors for Prediction of Significant Angiographic Lesions in Stable Coronary Artery Disease.

Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.

Heart. 2008 Aug 15. [Epub ahead of print]

PMID: 18708421 [PubMed - as supplied by publisher]

13:

Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.

Lajer M, Tarnow L, Jorsal A, Parving HH.

Nephrol Dial Transplant. 2007 Nov;22(11):3235-9. Epub 2007 Jun 13.

PMID: 17567649 [PubMed - indexed for MEDLINE]

14:

Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the Heart and Soul Study.

Desai AS, Bibbins-Domingo K, Shlipak MG, Wu AH, Ali S, Whooley MA.

Eur J Heart Fail. 2007 Sep;9(9):886-91. Epub 2007 Jul 12.

PMID: 17627881 [PubMed - indexed for MEDLINE]

15:

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH.

Diabetologia. 2005 Jan;48(1):149-55. Epub 2004 Dec 23.

PMID: 15616804 [PubMed - indexed for MEDLINE]

16:

Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.

Yip HK, Sun CK, Chang LT, Chen MC, Liou CW.

Circ J. 2006 Apr;70(4):447-52.

PMID: 16565563 [PubMed - indexed for MEDLINE]

18:

Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.

Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H.

Clin Endocrinol (Oxf). 2005 Nov;63(5):493-8.

PMID: 16268799 [PubMed - indexed for MEDLINE]

19:

Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.

Rothenbacher D, Koenig W, Brenner H.

Arch Intern Med. 2006 Dec 11-25;166(22):2455-60.

PMID: 17159010 [PubMed - indexed for MEDLINE]

20:

N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.

Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A.

Cardiology. 2006;106(2):102-8. Epub 2006 Apr 21.

PMID: 16636540 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 103
of 6Next